Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03995186
Other study ID # Beh_Act_ETB
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 20, 2019
Est. completion date September 30, 2021

Study information

Verified date May 2023
Source University of Oxford
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Behavioural activation (BA) is widely accepted as an efficacious treatment for depression. It has been suggested that several depression treatments work via early changes in emotional processing (e.g. affective bias in the processing of facial expressions) and that these could help predict treatment success, but it has not yet been examined whether the same applies in behavioural interventions. The investigators will examine how BA affects early emotional information processing in participants who are currently experiencing low mood, to see whether this can predict eventual changes in mood and to gain a better understanding of the treatment mechanisms of BA. Participants will be in three groups undergoing either behavioural activation, or activity monitoring alone (active control) for 4 weeks, or they will be on a waiting list (passive control). The investigators will also examine whether other factors, such as anxiety, social support and environmental reward, can predict the success of BA. This could help us understand how BA works and who may be most suitable for this intervention.


Recruitment information / eligibility

Status Completed
Enrollment 97
Est. completion date September 30, 2021
Est. primary completion date September 30, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Female or male - Age: 18 to 65 years - Competency to give informed consent - Scores above 14 on BDI-2 (bottom criterion for mild depression) Exclusion Criteria: - Previous participation in a study that used the emotional test battery (ETB) - Currently undergoing any form of psychotherapy or counselling - Taking antidepressant medication for less than 3 months, or changing existing psychiatric medication within the past month - Current or past a diagnosis of psychosis or a bipolar disorder - Current diagnosis of an eating disorder, a borderline personality disorder, or a substance abuse disorder - Any other factor that would indicate the participant isn't able to comply with the requirements of the study according to the opinion of the chief investigator (severe insomnia, chronic fatigue syndrome, neurological conditions impairing cognitive function etc.) - Symptoms of depression are too severe (score 20 and above on the PHQ-9 questionnaire or according to the evaluation of study psychiatrist)

Study Design


Intervention

Behavioral:
Behavioural activation
4-week programme based on the behavioural activation treatment provided in the NHS IAPT services. The programme includes psychoeducation on the relationship between activity and depression, examining the depressed person's level of activity, helping them identify activities they would like to increase and supporting them in the planning and conduct of those activities.
Activity monitoring
4-week programme where participants simply monitor their general daily activities in a diary.

Locations

Country Name City State
United Kingdom University of Oxford Oxford

Sponsors (1)

Lead Sponsor Collaborator
University of Oxford

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in recognition of positive and negative facial expressions from baseline at week 2 and 4 Hit rate for detecting positive versus negative faces in a facial expression recognition task (FERT) Will be assessed at week 0, week 3 and week 5 of the intervention
Secondary Median scores on the daily Mood Zoom questionnaire Scoring six emotions (Anxious, Elated, Sad, Angry, Irritable and Energetic) on a Likert scale (scale range 1-7). Higher values represent higher levels of the emotion. The six subscales will be combined into 'Positive affect' (Elated, Energetic), 'Negative affect' (Sad, Anxious) and 'Irritability' (Angry, Irritable) scores by averaging. 5 weeks
Secondary Motor activity Motor activity (in Hz) as measured by the GeneActive actigraphy watch 5 weeks
Secondary Change in speed during recognition of positive and negative facial expressions Reaction times for correctly recognised positive versus negative faces in facial expression recognition task (FERT) Will be assessed at week 0, week 3 and week 5 of the intervention
Secondary Change in emotional categorisation (ECAT) Reaction times for correctly classifying positive versus negative personality characteristic words Will be assessed at week 0, week 3 and week 5 of the intervention
Secondary Change in recall in the Emotional memory task (EREC) Number of positive and negative words correctly (and incorrectly) recalled in the EREC task Will be assessed at week 0, week 3 and week 5 of the intervention
Secondary Change in reward sensitivity Sensitivity to reward as measured by the Probabilistic Instrumental Learning Task Will be assessed at week 0, week 3 and week 5 of the intervention
Secondary Change in performance on Auditory Verbal Learning Task (AVLT) Accuracy on AVLT (number of items recalled across blocks) Will be assessed at week 0, week 3 and week 5 of the intervention
Secondary Change in levels of behavioural activation Score on the Behavioural Activation for Depression Scale (total score range 0-150). Higher scores indicate higher levels of activation. Will be assessed at week 0, week 3 and week 5 of the intervention
Secondary Change in mood Score on the Beck Depression Inventory (total score range 0-63). Higher scores indicate higher levels of depression. Will be assessed at week 0, week 3 and week 5 of the intervention
Secondary FERT as a possible predictor of mood change Correlation between Hit rate on the FERT at week 3 and the change in BDI at week 5 Will be assessed at week 3 and week 5 of the intervention
Secondary Change in environmental reward Score on the Environmental reward observation scale (total score range 10-40). Higher scores indicate higher levels of environmental reward. Will be assessed at week 0, week 3 and week 5 of the intervention
Secondary Change in subjective experience of social support Score on the Multidimensional Scale of Perceived Social Support (total score range 12-84). Higher scores indicate higher levels of support. Will be assessed at week 0, week 3 and week 5 of the intervention
Secondary Change in anxiety Score on the State-trait anxiety inventory (both State anxiety and Trait anxiety subscales scores range from 20-80). Higher scores indicate higher levels of anxiety. Will be assessed at week 0, week 3 and week 5 of the intervention
Secondary EREC as a possible predictor of mood change Correlation between number of correctly recalled positive versus negative personality characteristic words at week 3 and and the change in BDI score at week 5 Will be assessed at week 3 and week 5 of the intervention
Secondary ECAT as a possible predictor of mood change Correlation between reaction times for correctly classifying positive versus negative personality characteristic words at week 3 and the change in BDI score at week 5 Will be assessed at week 3 and week 5 of the intervention
Secondary FERT as a possible predictor of mood change Correlation between Reaction times on the FERT at week 3 and the change in BDI at week 5 Will be assessed at week 3 and week 5 of the intervention
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05777044 - The Effect of Hatha Yoga on Mental Health N/A
Recruiting NCT04977232 - Adjunctive Game Intervention for Anhedonia in MDD Patients N/A
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Completed NCT04512768 - Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy N/A
Recruiting NCT03207828 - Testing Interventions for Patients With Fibromyalgia and Depression N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Completed NCT04476446 - An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives Phase 3
Recruiting NCT02783430 - Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease Phase 2/Phase 3
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT04598165 - Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support N/A
Completed NCT03457714 - Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
Recruiting NCT05956912 - Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
Completed NCT05588622 - Meru Health Program for Cancer Patients With Depression and Anxiety N/A
Recruiting NCT05234476 - Behavioral Activation Plus Savoring for University Students N/A
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Enrolling by invitation NCT03276585 - Night in Japan Home Sleep Monitoring Study
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT03275571 - HIV, Computerized Depression Therapy & Cognition N/A